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        Hepatocyte growth factor (HGF), also known as scatter factor, 
binds to its receptor, the c-Met tyrosine kinase, to induce cell 
proliferation, migration, morphogenesis, and survival. These var-
ied responses are the result of diverse signaling pathways, includ-
ing those activating ERK1/2, STAT3, Rac, and Akt (  Birchmeier 
et al., 2003  ). In many cancers, c-Met is overexpressed, acti-
vated, amplifi  ed, and/or mutated and, thus, it is a major proto-
oncogene heavily targeted for therapy (for review see  Comoglio 
et al., 2008  ). How exactly the different pathways downstream 
of HGF/c-Met are specifi  cally regulated and coordinated still 
remains elusive. 
 One downstream signaling molecule of c-Met is the multi-
functional transcription factor STAT3 (signal transducer and 
activator of transcription). Under basal conditions, unphosphory-
lated STAT3 constitutively cycles between the cytoplasm and 
the nucleus (  Liu et al., 2005  ). Binding of HGF to c-Met results 
in recruitment of STAT3 to c-Met, the phosphorylation of STAT3, 
and STAT3 nuclear accumulation (  Boccaccio et al., 1998  ). 
The fi  rst suggestion that endocytosis might be important for 
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STAT3 signaling came from experiments showing that EGF 
stimulation of cells resulted in STAT3 localization to endo-
somes and endocytosis was important for STAT3-dependent 
transcription (  Bild et al., 2002  ). Endocytosis was later demon-
strated to be involved in some HGF-mediated signaling events 
(  Hammond et al., 2003  ;   Kermorgant et al., 2003  ,   2004  ) includ-
ing HGF-induced Rac traffi  cking in cell migration (  Palamidessi 
et al., 2008  ). The questions of why c-Met  –  dependent STAT3 
activation should require transport to endosomes instead of free 
diffusion through the cytoplasm and of how universal this mode 
of STAT3 signaling is remain a mystery. 
  In this issue of the Journal of Cell Biology, Kermorgant 
and Parker (see p. 855) provide a possible answer to these 
questions by demonstrating an unexpected relationship between 
the strength of the signaling response (e.g., activation by phos-
phorylation) and the traffi  cking of the receptor and downstream 
signaling components. The authors compared the activation of 
ERK1/2 and STAT3 with the intracellular traffi  cking of c-Met 
in response to HGF stimulation. The authors found that HGF 
elicits a potent activation of ERK1/2 that requires internaliza-
tion of c-Met into endosomes but does not require its traffi  cking 
to a perinuclear compartment (Fig. 1). In contrast, STAT3 acti-
vation is comparatively   “  weak  ”   and requires the localization of 
active c-Met to the perinuclear region via a microtubule and 
PKC    -dependent process (Fig. 1). Interestingly, STAT3 activa-
tion via the cytokine Oncostatin M produces a   “  stronger  ”   signal 
that occurs independently of microtubules and PKC     (Fig.  1). 
This result demonstrates that the traffi  cking of STAT3 to endo-
somes is not an absolute requirement for activity but rather 
depends on the   “  signal strength  ”   elicited by the growth factor  –
  receptor complex. The involvement of the endocytic pathway in 
STAT3 signaling was also recently shown for IL-6 and, if it fol-
lows the trend established here, then one would predict the IL-6  –
  mediated STAT3 signal also to be weak (  Shah et al., 2006  ). 
 The  fi  ndings presented in this study pose several interesting 
problems for the entire fi  eld of receptor-mediated signaling and 
membrane traffi  cking. Increasing evidence has been accumulat-
ing in favor of the  “ signaling endosome ”  hypothesis, whereby 
signals are sustained or generated on endosomes and compart-
mentalization is exploited to generate quantitative and qualitative 
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  Another question is which type of endosomal compart-
ment is involved in c-Met  –  dependent STAT3 signaling? The 
identity of the perinuclear endosomal compartments accessed 
by c-Met over time has not yet been well characterized. Signal-
ing could be elicited from recycling endosomes or late endo-
cytic compartments, both of which are positioned mainly in the 
perinuclear region of the cell. This question is important in view 
of recent data implicating a newly identifi  ed endosomal com-
partment (APPL-positive endosomes) with an unexpected role 
in signal specifi  city (  Miaczynska et al., 2004  ;   Schenck et al., 
2008  ). As shown for several receptors (  Lin et al., 2006  ;   Mao 
et al., 2006  ;   Erdmann et al., 2007  ), c-Met (at least a fraction of 
receptor) could also enter and signal from APPL endosomes. 
It would be informative to determine if there is also a STAT3 
APPL-positive endosomal population and, if so, whether there 
is a functional specifi  city to this endosomal STAT3 signal. 
 Interestingly, the transport of transcription factors via endo-
somes to a perinuclear location and the concomitant evidence 
of endosomal proteins found in the nucleus suggest that there is 
a widespread role for endocytic proteins in transcriptional regu-
lation (  Pilecka et al., 2007  ). The authors of the present study did 
not address the transcriptional activity of STAT3 but, instead, 
equated nuclear presence to transcriptional activity. Are there, in 
fact, functional differences between the transcriptional profi  les 
of soluble cytosolic STAT3 versus STAT3 activated on endo-
somes? STAT3 has recently been shown to have an additional 
role in the cytoplasm. It can bind to the microtubule binding pro-
tein stathmin and antagonize its microtubule destabilizing activ-
ity leading to a reorganization of the microtubule network (  Ng 
et al., 2006  ). Clearly, we need to explore further the role of sig-
naling molecules as traffi  cking regulators, as signal transduction 
is known to modulate membrane and cytoskeleton dynamics. 
  The functional outcome of c-Met activation is a fi  ne balance 
between signaling pathways using diffusion and those requiring 
endosomal traffi  cking. As presented in this issue, HGF binding 
to c-Met results in the compartmentalization of activated STAT3 
to endosomes thus allowing a weak signal to reach the nucleus. 
These studies have been conducted in HeLa cells as a model 
system. Next, it will be important to validate the conclusions of 
this study in model organisms, where mechanistic differences 
can be highlighted under physiological conditions. 
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